🔎 Trials Near Me

Home › Meningioma › Florida › Miami

Pag-aaral pangklinika para sa Meningioma sa Miami, FL

Isang pag-aaral para sa Meningioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Miami. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Nagre-recruitPhase 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT02523014

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Nagre-recruitPhase 2
  • University of Miami, Miami
  • Baptist Health Medical Group Oncology, Miami
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06955169

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Nagre-recruitPhase 2
  • Baptist Health Miami Cancer Institute, Miami
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07428616

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Nagre-recruitPhase 2
  • University of Miami, Miami
Edad 12 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04374305

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Nagre-recruitObservasyonal na pag-aaral
  • Miami Cancer Institute, Baptist Health South Florida, Miami
Lahat ng edad · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04427384

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Nagre-recruitPhase 2
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT05425004

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Nagre-recruitPhase 1/2
  • Biogenix Molecular, Miami
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update May 14, 2026 · NCT05636618

Pag-aaral para sa Meningioma sa ibang lungsod

Iba pang pag-aaral sa Miami

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.